BACKGROUNDBreast cancer is a heterogeneous disease with variable morphological features, clinical outcomes and response to different therapeutic options. Gene expression profiling studies on breast carcinomas have revolutionised the classification of breast carcinomas into molecular subtypes enhancing the treatment protocols and offering better prediction of outcomes. MATERIALS AND METHODSThe present study aims to discuss the special histological variants with special emphasis on their molecular phenotype using surrogate immunohistochemical markers. RESULTSSpecial variants of breast carcinomas diagnosed during the study period of two years from August 2013 and July 2015 were classified into molecular subtypes using immunohistochemical expression of ER, PR and HER-2. CONCLUSIONSSpecial types of breast carcinomas are very rare and have different clinicopathologic behaviours. It is important to know their characteristics to make proper management decisions and to predict the prognosis. KEYWORDSIHC, Molecular Typing of Breast Carcinomas, Special Types of Breast Cancers. HOW TO CITE THIS ARTICLE: Mekhala PM, Aruna L, Arasi NE, et al. Immunohistochemistry as surrogate marker for molecular typing of special types of breast carcinomas.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.